Apple (AAPL) Announces New Autism, Epilepsy and Melanoma Studies for ResearchKit
Tweet Send to a Friend
Apple (NASDAQ: AAPL) announced that ResearchKit is enabling new research studies on autism, epilepsy and melanoma. ResearchKit turns iPhone® into ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE